| Names | |
|---|---|
| IUPAC name 3,4-Dihydroxy-D-phenylalanine | |
| Systematic IUPAC name (2R)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider | |
| ECHA InfoCard | 100.024.858 |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C9H11NO4 | |
| Molar mass | 197.19 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
d-DOPA(D-3,4-dihydroxyphenylalanine;dextrodopa) is similar to L-DOPA (levodopa), but with opposite chirality. [1] Levo- and dextro- rotation refer to a molecule's ability to rotate planes of polarized light in one or the other direction. Whereas L-DOPA is moderately effective in the treatment of Parkinson's disease (PD) and dopamine-responsive dystonia (DRD) by stimulating the production of dopamine in the brain, D-DOPA is biologically inactive.
Avoiding unwanted production of D-DOPA is a goal for commercial synthesis of L-DOPA-based drugs to treat Parkinson's disease. [1]